Global Metastatic Gastric Cancer Treatment Market: Overview

  • Gastric cancer (GC) is the second-leading cause of cancer-related mortality worldwide and is also responsible for a significantly high cancer burden, as measured by disability-adjusted life years lost. The World Health Organization estimates that in 2018, gastric cancer accounted for 783,000 deaths worldwide. Approximately 50 to 65% of GC patients present with locally advanced or metastatic disease, and the majority would have systemic disease at some time during the course of their illness.
  • Gastric cancer incidence and mortality are highly variable by region and highly dependent on diet and Helicobacter pylori infection. Gastric cancer is more prevalent in males. In developed countries, gastric cancer is 2.2 times more likely to be diagnosed in males than females.

Key Drivers and Restrains of Global Metastatic Gastric Cancer Treatment Market

  • Favorable reimbursement in developed countries, adoption of combination therapy such as chemotherapy with immunotherapy drugs that effectively work in the stage III or IV gastric cancer. Doctors are also opting for chemotherapy before surgery, called neoadjuvant therapy, or after surgery, called adjuvant therapy to treat metastatic gastric cancer, which is likely to drive the metastatic gastric cancer treatment market.
  • However, low survival rate of metastatic gastric cancer and high cost associated with the immunotherapy treatment procedures are likely to restraint the market during the forecast period

North America to Account for Major Share of Global Metastatic Gastric Cancer Treatment Market

  • In terms of region, the global metastatic gastric cancer market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
  • North America is projected to dominate the global market during the forecast period. The region is anticipated to account for a significant share of the global market due to wide availability of immunotherapy drugs and favorable reimbursement scenario.
  • The market in Asia Pacific is driven by sustainable growth trends across all clinical fields in countries in the region and consequent increase in number of cases. Moreover, Latin America recorded high prevalence of H. pylori infection and the region has highest gastric cancer incidence rate in the world. According to GLOBOCAN data, in 2018, more than 51,000 gastric cancer cases were diagnosed in Latin America.

Key Players Operating in Global Metastatic Gastric Cancer Treatment Market

Major players operating in the global metastatic gastric cancer treatment market are:

  • F. Hoffmann-La Roche AG
  • Eli Lilly and Company
  • Merck & Co., Inc.
  • Sun Pharmaceutical Ltd.
  • Sanofi S.A
  • Teva Pharmaceutical Industries Ltd.

Global Metastatic Gastric Cancer Treatment Market: Research Scope

Global Metastatic Gastric Cancer Treatment Market, by Treatment

  • Chemotherapy
    • Docetaxel
    • Doxorubicin Hydrochloride
    • Fluorouracil Injection
    • Others
  • Immunotherapy
    • Ramucirumab
    • Trastuzumab
    • Pembrolizumab
  • Radiation Therapy

Global Metastatic Gastric Cancer Treatment Market, by Indication

  • Gastric Adenocarcinoma
  • Gastrointestinal Stroma Tumor
  • Others

Global Metastatic Gastric Cancer Treatment Market, by Distribution Channel

  • Hospitals Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

This upcoming business intelligence report is intended to be a one-stop market research solution to guide organizations in taking timely and effective decisions for their business growth. The ongoing study is the culmination of our deep expertise on data science methods, combined with an unparalleled understanding of the external environment and analysis of the industries. Each of the reports by TMR aims at offering a detailed scrutiny of the value chain of our current and prospective customers, takes them from identifying value propositions, and subsequently assist their business executives to implement right strategies to create customer value. We believe that creating and sustaining the customer value is the key pivot on which business executives can create profits for their organizations and increase the market shares, continuously and with sustainability.

Each of our touchpoints through which we engage with the organization/enterprise during the primary research enables us to understand the internal environment it operates in and the ways in which the external environment influences its growth.

Always Evolving with Competition

Excellence is built into the DNA of TMR, and all our teams work collaboratively and committedly toward achieving that in whatever they do. From the very first interaction our teams of research analysts have with any interested market participant to the final preparation processes in each of our reports reflects a rigorous understanding of the dynamic industry environment that businesses operate in.

We relentlessly work to be a differentiator in whatever we do in the current era of hypercompetitive global environment. The result of our unceasing focus on excellence is reflected clearly in the insights and guidance we offer to our customers in order to empower them to create brand equity. Our simple yet very powerful underpinning for navigating the competition is to always keep evolving with changing business environments. Our close-kinit team of research analysts not only believe in this simple philosophy but also implement the same.

Constantly Innovating Our Research Methodologies and Models

We do not limit with any specific market research tool or one standard approach for obtaining or analyzing data. Undoubtedly, our report making process is ever-evolving to meet the customer needs and demands supported broadly by a vast knowledge of data science methods that we combine with business acumen our teams have built upon for several years. Evidently, our primary and secondary research data about customers and consumers have shown that we can go to any lengths to obtain them. This is followed by applying next-gen automation tools integrated with human judgement to clear the clutter, ascertain the most relevant and recent qualitative and quantitative insights, and package them in digestible chunks in our reports for our customers.

We Take Pride in No-One-Size-Fits-All Approach

Over the past several years, we have been conducting market intelligence studies across all industries for all types of organizations — big and small, profit and not-for-profit, and Fortune 500 and Unicorns, as we believe that a sound decision making must be based on no-one-size-fits-all approach. Without doubt, each of the organizations regardless of the industry they are in are affected differently by changes in political, economic, socio-culture, legal, ecological, and legal environments. The research models and the value chain analysis process that our analysts employ for conducting the study uphold this approach.

We look at myriad components of internal and external business environment affecting the growth strategies of organizations. Some of the broader aspects that we focus on are:

  • Our team of Analysts and Support Teams always strive to see the bigger picture in life cycle stages of any industry
  • The Teams focus on obtaining valuable insights into different models of competitive advantage while making an internal environment analysis
  • They keep on modifying the value chain analysis processes of organizations to understand on how customer value is created

Some areas of assessing market dynamics that are used in the research models and methodologies adopted by our analysts can be summarized as:

  • Corporate and business strategies underlying new brand positioning strategies
  • Mapping for strategic planning for business units
  • Various metrics for business portfolio analysis, including BCG matrix
  • Value chain analysis

These will help create and sustain competitive advantage for our prospects and current customers.

Key focus areas and agenda that underpin and catalyze our primary and secondary research initiatives and endeavors are:

  • What are some of the core competencies and distinctive competencies of new entrants and established players in the industry we are analyzing?
  • What are some of the branding opportunities that are emerging at a rapid pace?
  • What are the major competitive forces and elements of external environment shaping the industry life cycle stages of most organizations?
  • Why some competitive strategies are popular than others among leaders in a certain market?
  • What customer-based brand equity strategies companies have leveraged in a certain industry or set of related industries in a sector?
  • What are some of the key pricing strategies that companies in an industry are implementing for marketing their products internationally?
  • Identifying whether market-push or market-pull strategies are more relevant to a certain product or a service?

Disclaimer: This ongoing market research study is a meticulously planned activity where a broad array of factors and aspects that shape the marketing environment and industry are taken into account. However, keeping in mind the constantly changing nature of business dynamics and changing strategic intents, we are always actively making iterations and modifications in our approaches. As always, we are ready to tailor our insights and guidance to suit your requirements. Engage with us to know what more is there for your CXOs.

Enquiry Before Buying

TMR offers Enquiry Before Buying that help clients to get information on their business scenario required where syndicated solutions are not enough.

Enquiry Before Buying

Metastatic Gastric Cancer Treatment Market